Cargando…
Management of uterine sarcomas and prognostic indicators: real world data from a single-institution
BACKGROUND: Uterine sarcomas consist a heterogeneous group of mesenchymal gynecological malignancies with unclear therapeutic recommendations and unspecific but poor prognosis, since they usually metastasize and tend to recur very often, even in early stages. METHODS: We retrospectively analyzed all...
Autores principales: | Kyriazoglou, Anastasios, Liontos, Michael, C Ziogas, Dimitrios, Zagouri, Flora, Koutsoukos, Kostantinos, Tsironis, Giorgos, Tsiara, Anna, Kaparelou, Maria, Zakopoulou, Roubini, Thomakos, Nikolaos, Haidopoulos, Dimitrios, Papaspyrou, Irene, Rodolakis, Alexandros, Bamias, Aristotelis, Dimopoulos, Meletios Athanasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292121/ https://www.ncbi.nlm.nih.gov/pubmed/30541504 http://dx.doi.org/10.1186/s12885-018-5156-1 |
Ejemplares similares
-
Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
por: Liontos, Michalis, et al.
Publicado: (2021) -
What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience
por: Liontos, Michalis, et al.
Publicado: (2021) -
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
por: Andrikopoulou, Angeliki, et al.
Publicado: (2023) -
Axitinib as a third or further line of treatment in renal cancer: a single institution experience
por: Tsironis, G., et al.
Publicado: (2020) -
Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience
por: Kaparelou, Maria, et al.
Publicado: (2022)